Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 36.00
-2.55 (-6.61%)
May 8, 2026, 1:30 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 4.49 billion as of May 8, 2026. Its market cap has decreased by -34.53% in one year.
Market Cap
4.49B
Enterprise Value
4.47B
Revenue
597.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
Market Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 4.49B, an increase of 903.32%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 4.49B | 0.56% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 9.15B |
| Formosa Laboratories | 6.53B |
| Orient Pharma | 5.81B |
| LIWANLI Innovation | 5.68B |
| SCI Pharmtech | 5.58B |
| Orient EuroPharma | 4.04B |
| Merdury Biopharmaceutical | 3.37B |
| Allied Biotech | 3.07B |